In an editorial accompanying the study, M. Constanza Camargo, PhD, MSc, of the National Cancer Institute, noted that in a ...

Functional dyspepsia is a common digestive disorder, with more than one in ten Koreans suffering. Some of these patients wander from one hospital to another, searching for a precise cause and ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Cobenfy doesn’t have the same severe side effects as older schizophrenia medications — like weight gain, involuntary muscle ...

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...

Whether it's a treatment grandma recommended or one your best friend tells you about, we've all heard numerous examples of how something from our kitchen could help us feel better quickly. An episode ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of ...

One of the stranger legends surrounding the controversial Confederate general Stonewall Jackson is the fact that Jackson's ...

Bristol-Myers Squibb received FDA's approval for Cobenfy, which is poised to be a game changer in the treatment of ...